BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3956109)

  • 1. Contribution of vasopressin to the maintenance of blood pressure in deoxycorticosterone-salt induced malignant hypertension in spontaneously hypertensive rats.
    Hiwatari M; Abrahams JM; Saito T; Johnston CI
    Clin Sci (Lond); 1986 Feb; 70(2):191-8. PubMed ID: 3956109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Tatsumi Y; Yoshikawa J
    Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against a vasopressor role of ADH in malignant DOC-salt hypertension.
    Filep J; Frölich JC; Fejes-Toth G
    Clin Exp Hypertens A; 1985; 7(10):1457-70. PubMed ID: 3841034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOCA-salt induced malignant hypertension in spontaneously hypertensive rats.
    Sesoko S; Pegram BL; Willis GW; Frohlich ED
    J Hypertens; 1984 Feb; 2(1):49-54. PubMed ID: 6530537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does vasopressin sustain blood pressure in conscious spontaneously hypertensive rats?
    Filep J; Fejes-Tóth G
    Hypertension; 1986 Jun; 8(6):514-9. PubMed ID: 2872162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin compensates for acute loss of sympathetic pressor tone in spontaneously hypertensive rats.
    Jablonskis LT; Howe PR
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):380-3. PubMed ID: 8324928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented central pressor action of magnesium in SHR.
    Oda S; Seto S; Akahoshi M; Nagao S; Ozeki S; Kusano S; Yano K; Hashiba K
    Am J Med Sci; 1993 Oct; 306(4):218-24. PubMed ID: 8213889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressor response to vasopressin and norepinephrine in DOC-salt hypertensive and prehypertensive rats.
    Ouchi Y; Yazaki Y; Tsai RC; Ashida T
    Tohoku J Exp Med; 1988 Feb; 154(2):125-33. PubMed ID: 3381222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine fails to reduce pressor responsiveness of conscious spontaneously hypertensive rats to vasopressin.
    Datar S; Laverty WH; McNeill JR
    Can J Physiol Pharmacol; 1986 Mar; 64(3):284-9. PubMed ID: 3708435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and malignant deoxycorticosterone hypertension in rats.
    Möhring J; Möhring B; Petri M; Haack D
    Clin Sci Mol Med Suppl; 1976 Dec; 3():45s-48s. PubMed ID: 1071663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vasopressin and V1 receptors blockade on hypotensive action of ANP in normotensive (WKY) and spontaneously hypertensive rats.
    Lapiński M; Stepniakowski K; Januszewicz A; Noszczyk B; Szczepańska-Sadowska E
    J Physiol Pharmacol; 1992 Mar; 43(1):65-78. PubMed ID: 1450435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressor actions of arginine vasopressin in pithed Sprague-Dawley, Wistar-Kyoto and spontaneously hypertensive rats before and after treatment with nifedipine or pertussis toxin.
    Tabrizchi R; Triggle CR
    J Hypertens; 1991 Sep; 9(9):813-8. PubMed ID: 1663982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NG-nitro-L-arginine on pressor action of arginine vasopressin in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
    Styś T; Szczepańska-Sadowska E
    J Physiol Pharmacol; 1994 Jun; 45(2):231-40. PubMed ID: 7949233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cold pressor response in spontaneously hypertensive rats on high-NaCl diet.
    Thornton RM; Davidson JM; Oparil S
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1018-23. PubMed ID: 3189566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin receptors and inositol trisphosphate production in blood vessels of spontaneously hypertensive rats.
    Larivière R; Baribeau J; St-Louis J; Schiffrin EL
    Can J Physiol Pharmacol; 1989 Mar; 67(3):232-9. PubMed ID: 2525949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma immunoreactive endothelin-1 in experimental malignant hypertension.
    Kohno M; Murakawa K; Horio T; Yokokawa K; Yasunari K; Fukui T; Takeda T
    Hypertension; 1991 Jul; 18(1):93-100. PubMed ID: 1860718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of spontaneous hypertension in rats by a vasopressin antagonist.
    Sladek CD; Blair ML; Sterling C; Mangiapane ML
    Hypertension; 1988 Nov; 12(5):506-12. PubMed ID: 3056858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.